1G. Bodey,B. Bueltmann,W. Duguid,D. Gibbs,H. Hanak,M. Hotchi,G. Mall,P. Martino,F. Meunier,S. Milliken,S. Naoe,M. Okudaira,D. Scevola,J. Wout. Fungal infections in cancer patients: An international autopsy survey[J] 1992,European Journal of Clinical Microbiology & Infectious Diseases(2):99～109
同被引文献13
1Giamarellou H. Empiric therapy for infections in the febrile, neutropenic, compromised host. Med Clin North Am, 1995,79(3) :559 - 580.
2Pizzo PA. Management of fever in patients with cancer and treatmentinduced neutropenia. N Engl J Med,1993,328(18) :1323- 1332.
3Gora- Tybor J, Krykowski E,RobakT. Treatment of drug induced agranulocytosis with colony stimulating factors(G - CSF, GM - CSF). Immnol Ther Exp, 1996,44(4) :255 - 258.
4Hurtado R, Cardelaria M, Majlut- Cruz A, et al. Drug - induced agranulocytosis treated with granulocyte- macrophage colony stimulating factor.Rev Invest Clin,1994,46(1) :59- 61.
5Nelson WK, Rayback PA, Quinones R, et al. Empiric carbapenem monotherapy in pediatric bone marrow transplant recipients [ J ]. Ann Pharmacother,2002,36 : 1360-1365.
6Paterson DL, Ko WC, Gottberg AV, et al. International prospective study of Klebsiella pneumoniae bacteremia:implications of Extended-Spectrum 13-Lactamase production in nosocomial infections [ J ]. Ann Intern Med,2004,140:26-32.
